Channel profile image
Talks (131)
LHBT_10
Sep 27
LHBT_9
Sep 27
LHBT_8
Sep 27
LHBT_7
Sep 27
LHBT_6
Sep 27
LHBT_5
Sep 27
LHBT_4
Sep 27
LHBT_3
Sep 26
LHBT_2
Sep 26
LHBT
Sep 26
IBSsurvey_10
Sep 01
IBSsurvey_9
Sep 01
IBSsurvey_8
Aug 29
IBSsurvey_7
Aug 29
IBSsurvey_6
Aug 29
IBSsurvey_5
Aug 29
IBSsurvey_4
Aug 29
IBSsurvey_3
Aug 29
IBSsurvey_2
Aug 29
IBSsurvey_1
Aug 29
IBSD Rifaximin MMX 1
Jul 31
IBSD Rifaximin MMX 2
Jul 31
IBSD Rifaximin MMX 3
Jul 31
IBSD Rifaximin MMX 4
Jul 31
IBSD Rifaximin MMX 5
Jul 31
IBSD Rifaximin MMX 6
Jul 31
IBSD Rifaximin MMX 7
Jul 31
IBSD Rifaximin MMX 8
Jul 31
IBSD Rifaximin MMX 9
Jul 31
IBSD Rifaximin MMX 10
Jul 31
Reducing Bias Through Real-Time Data
Jul 27
Capturing Symptom Interactions
Jul 27
Advancing Precision Medicine in IBS
Jul 27
Usability and Compliance
Jul 27
Reliability Despite Symptom Variability
Jul 27
Internal Consistency Across Symptom Doma
Jul 27
Weaker Correlations With End-of-Week Too
Jul 27
Retrospective Bias in End-of-Day Diaries
Jul 27
High Adherence Supports ESM Feasibility
Jul 19
Validating Real-Time Symptom Assessment
Jul 19
Intestinal Persistence SARS-CoV2
Jul 10
IBS_ Mediterranean10
Jun 19
IBS_ Mediterranean9
Jun 19
IBS_ Mediterranean8
Jun 19
IBS_ Mediterranean7
Jun 19
IBS_ Mediterranean6
Jun 19
IBS_ Mediterranean5
Jun 19
IBS_ Mediterranean4
Jun 19
IBS_ Mediterranean3
Jun 19
IBS_ Mediterranean2
Jun 19
IBS_ Mediterranean1
Jun 19
Microbiome and IBS therapies
May 27
Microbiome and IBS therapies
May 27
Low FODMAP and microbiome
May 27
Low FODMAP & Microbiome Metabotype
May 27
Restrictive dietary patterns
May 27
Diet & short chain fatty acids
May 27
Short chain fatty acids & IBS
May 27
Short chain fatty acids & IBS
May 27
Microbiome in IBS-2
May 27
Loading logo